يعرض 1 - 7 نتائج من 7 نتيجة بحث عن '"Valdez, Benigno C"', وقت الاستعلام: 1.20s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Synergistic cytotoxicity of fludarabine, clofarabine, busulfan, vorinostat and olaparib in AML cells.

    المؤلفون: Valdez, Benigno C., Bin Yuan, Murray, David, Ramdial, Jeremy Leon, Nieto, Yago, Popat, Uday, Xiaowen Tang, Andersson, Borje S.

    المصدر: Frontiers in Oncology; 2023, p1-11, 11p

    مصطلحات موضوعية: BUSULFAN, FLUDARABINE, CYTOTOXINS, DNA repair, HEMATOPOIETIC stem cell transplantation, ACUTE myeloid leukemia, OLAPARIB

    النص الكامل

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Romidepsin enhances the cytotoxicity of fludarabine, clofarabine and busulfan combination in malignant T-cells.

    المؤلفون: Valdez, Benigno C.1 bvaldez@mdanderson.org, Brammer, Jonathan E.1, Li, Yang1, Murray, David2, Teo, Esmeralda C.3, Liu, Yan1, Hosing, Chitra1, Nieto, Yago1, Champlin, Richard E.1, Andersson, Borje S.1

    المصدر: Leukemia Research. Aug2016, Vol. 47, p100-108. 9p.

    مصطلحات موضوعية: *ANTINEOPLASTIC agents, *FLUDARABINE, *ANTIMETABOLITES, *T cells, *BUSULFAN, *DRUG synergism, *GLUTATHIONE, *MITOCHONDRIAL membranes, *CANCER


    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    Synergistic Cytotoxicity of Sorafenib with Busulfan and Nucleoside Analogs in Human FMS-like Tyrosine Kinase 3 Internal Tandem Duplications–Positive Acute Myeloid Leukemia Cells.

    المؤلفون: Song, Guiyun1, Valdez, Benigno C.1, Li, Yang1, Liu, Yan1, Champlin, Richard E.1, Andersson, Borje S.1 bandersson@mdanderson.org

    المصدر: Biology of Blood & Marrow Transplantation. Nov2014, Vol. 20 Issue 11, p1687-1695. 9p.

    مصطلحات موضوعية: *NUCLEOSIDES, *LEUKEMIA, *ACUTE myeloid leukemia, *FLUDARABINE, *PROTEIN-tyrosine kinases

    النص الكامل

    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    Clofarabine ± Fludarabine with Once Daily i.v. Busulfan as Pretransplant Conditioning Therapy for Advanced Myeloid Leukemia and MDS

    المؤلفون: Andersson, Borje S.1 bandersson@mdanderson.org, Valdez, Benigno C.1, de Lima, Marcos1, Wang, Xuemei2, Thall, Peter F.2, Worth, Laura L.3, Popat, Uday1, Madden, Timothy4, Hosing, Chitra1, Alousi, Amin1, Rondon, Gabriela1, Kebriaei, Partow1, Shpall, Elizabeth J.1, Jones, Roy B.1, Champlin, Richard E.1

    المصدر: Biology of Blood & Marrow Transplantation. Jun2011, Vol. 17 Issue 6, p893-900. 8p.

    مصطلحات موضوعية: *FLUDARABINE, *MYELOID leukemia, *STEM cell transplantation, *ONCOLOGIC surgery, *LEUKEMIA treatment, *DISEASE relapse, *TRANSPLANTATION of organs, tissues, etc., *CLINICAL trials, *PHARMACOKINETICS

    النص الكامل

    أضف إلى المفضلة
  5. 5
    دورية أكاديمية
    The synergistic cytotoxicity of clofarabine, fludarabine and busulfan in AML cells involves ATM pathway activation and chromatin remodeling

    المؤلفون: Valdez, Benigno C.1 bvaldez@mdanderson.org, Li, Yang1 Yangli@mdanderson.org, Murray, David2 David.Murray5@albertahealthservices.ca, Champlin, Richard E.1 rchampli@mdanderson.org, Andersson, Borje S.1 bandersson@mdanderson.org

    المصدر: Biochemical Pharmacology. Jan2011, Vol. 81 Issue 2, p222-232. 11p.

    مصطلحات موضوعية: *CELL-mediated cytotoxicity, *FLUDARABINE, *IONIZING radiation, *HEMATOPOIETIC stem cell transplantation, *DNA damage, *BIOCHEMICAL mechanism of action, *APOPTOSIS


    أضف إلى المفضلة
  6. 6
    دورية أكاديمية
    Comparison of the cytotoxicity of cladribine and clofarabine when combined with fludarabine and busulfan in AML cells: Enhancement of cytotoxicity with epigenetic modulators.

    المؤلفون: Valdez, Benigno C.1 bvaldez@mdanderson.org, Li, Yang1, Murray, David2, Ji, Jie1, Liu, Yan1, Popat, Uday1, Champlin, Richard E.1, Andersson, Borje S.1

    المصدر: Experimental Hematology. Jun2015, Vol. 43 Issue 6, p448-461.e2. 1p.

    مصطلحات موضوعية: *CELL-mediated cytotoxicity, *FLUDARABINE, *BUSULFAN, *HEMATOPOIETIC stem cells, *MYELOID leukemia, *CANCER cells

    النص الكامل

    أضف إلى المفضلة
  7. 7
    دورية أكاديمية
    Long-Term Outcomes after Treatment with Clofarabine ± Fludarabine with Once-Daily Intravenous Busulfan as Pretransplant Conditioning Therapy for Advanced Myeloid Leukemia and Myelodysplastic Syndrome.

    المؤلفون: Alatrash, Gheath1, Thall, Peter F.2, Valdez, Benigno C.1, Fox, Patricia S.2, Ning, Jing2, Garber, Haven R.1, Janbey, Selma1, Worth, Laura L.3, Popat, Uday1, Hosing, Chitra1, Alousi, Amin M.1, Kebriaei, Partow1, Shpall, Elizabeth J.1, Jones, Roy B.1, de Lima, Marcos1,4, Rondon, Gabriela1, Chen, Julianne1, Champlin, Richard E.1, Andersson, Borje S.1 bandersson@mdanderson.org

    المصدر: Biology of Blood & Marrow Transplantation. Oct2016, Vol. 22 Issue 10, p1792-1800. 9p.

    مصطلحات موضوعية: *FLUDARABINE, *BUSULFAN, *MYELOID leukemia, *LEUKEMIA treatment, *MYELODYSPLASTIC syndromes treatment, *PROGRESSION-free survival, *SURVIVAL analysis (Biometry), *THERAPEUTICS

    النص الكامل

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث